{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["delivery technologies", "drug candidates", "osteoarthritis", "pathological mechanism", "treatment strategies"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36467045", "DateRevised": {"Year": "2022", "Month": "12", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "17"}], "Language": ["eng"], "ELocationID": ["945876", "10.3389/fphar.2022.945876"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Emerging pharmaceutical therapeutics and delivery technologies for osteoarthritis therapy.", "Pagination": {"StartPage": "945876", "MedlinePgn": "945876"}, "Abstract": {"AbstractText": ["Osteoarthritis (OA) is one of the most common joint degenerative diseases in the world. At present, the management of OA depends on the lifestyle modification and joint replacement surgery, with the lifespan of prosthesis quite limited yet. Effective drug treatment of OA is essential. However, the current drugs, such as the non-steroidal anti-inflammatory drugs and acetaminophen, as well as glucosamine, chondroitin sulfate, hyaluronic acid, are accompanied by obvious side effects, with the therapeutic efficacy to be enhanced. Recently, novel reagents such as IL-1 antagonists and nerve growth factor inhibitors have entered clinical trials. Moreover, increasing evidence demonstrated that active ingredients of natural plants have great potential for treating OA. Meanwhile, the use of novel drug delivery strategies may overcome the shortcomings of conventional preparations and enhance the bioavailability of drugs, as well as decrease the side effects significantly. This review therefore summarizes the pathological mechanisms, management strategies, and research progress in the drug molecules including the newly identified active ingredient derived from medicinal plants for OA therapy, with the drug delivery technologies also summarized, with the expectation to provide the summary and outlook for developing the next generation of drugs and preparations for OA therapy."], "CopyrightInformation": "Copyright \u00a9 2022 Shentu, Yan, Xu, Chen and Peng."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China."}], "LastName": "Shentu", "ForeName": "Cheng-Yu", "Initials": "CY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China."}], "LastName": "Yan", "ForeName": "Ge", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China."}], "LastName": "Xu", "ForeName": "Dong-Chen", "Initials": "DC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China."}], "LastName": "Chen", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, Macau SAR, China."}], "LastName": "Peng", "ForeName": "Li-Hua", "Initials": "LH"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Aida Y., Honda K., Tanigawa S., Nakayama G., Matsumura H., Suzuki N., (2012). IL-6 and soluble IL-6 receptor stimulate the production of MMPs and their inhibitors via JAK-STAT and ERK-MAPK signalling in human chondrocytes. Cell Biol. Int. 36, 367\u2013376. 10.1042/cbi20110150", "ArticleIdList": ["10.1042/cbi20110150", "22087578"]}, {"Citation": "Alisi A., Pastore A., Ceccarelli S., Panera N., Gnani D., Bruscalupi G., (2012). Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats. Int. J. Mol. Sci. 13, 2276\u20132289. 10.3390/ijms13022276", "ArticleIdList": ["10.3390/ijms13022276", "PMC3292022", "22408453"]}, {"Citation": "Argoff C. (2011). Mechanisms of pain transmission and pharmacologic management. Curr. Med. Res. Opin. 27, 2019\u20132031. 10.1185/03007995.2011.614934", "ArticleIdList": ["10.1185/03007995.2011.614934", "21916528"]}, {"Citation": "Astudillo P., R\u00edos S., Pastenes L., Pino A. M., Rodr\u00edguez J. P. (2008). Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action. J. Cell. Biochem. 103, 1054\u20131065. 10.1002/jcb.21516", "ArticleIdList": ["10.1002/jcb.21516", "17973271"]}, {"Citation": "Ayral X., Pickering E. H., Woodworth T. G., Mackillop N., Dougados M. (2005). Synovitis: A potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthr. Cartil. 13, 361\u2013367. 10.1016/j.joca.2005.01.005", "ArticleIdList": ["10.1016/j.joca.2005.01.005", "15882559"]}, {"Citation": "Bagherifard S., Tamayol A., Mostafalu P., Akbari M., Comotto M., Annabi N., et al. (2016). Dermal patch with integrated flexible heater for on demand drug delivery. Adv. Healthc. Mat. 5, 175\u2013184. 10.1002/adhm.201500357", "ArticleIdList": ["10.1002/adhm.201500357", "26501166"]}, {"Citation": "Balanescu A. R., Feist E., Wolfram G., Davignon I., Smith M. D., Brown M. T., et al. (2014). Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: A double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial. Ann. Rheum. Dis. 73, 1665\u20131672. 10.1136/annrheumdis-2012-203164", "ArticleIdList": ["10.1136/annrheumdis-2012-203164", "23852695"]}, {"Citation": "Ben-Eliezer M., Phillip M., Gat-Yablonski G. (2007). Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways. Endocrine 32, 235\u2013244. 10.1007/s12020-007-9025-y", "ArticleIdList": ["10.1007/s12020-007-9025-y", "18080100"]}, {"Citation": "Benito M. J., Veale D. J., FitzGerald O., van den Berg W. B., Bresnihan B. (2005). Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 64, 1263\u20131267. 10.1136/ard.2004.025270", "ArticleIdList": ["10.1136/ard.2004.025270", "PMC1755629", "15731292"]}, {"Citation": "Bindu S., Mazumder S., Bandyopadhyay U. (2020). Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem. Pharmacol. 180, 114147. 10.1016/j.bcp.2020.114147", "ArticleIdList": ["10.1016/j.bcp.2020.114147", "PMC7347500", "32653589"]}, {"Citation": "Bishnoi M., Jain A., Hurkat P., Jain S. K. (2016). Chondroitin sulphate: A focus on osteoarthritis. Glycoconj. J. 33, 693\u2013705. 10.1007/s10719-016-9665-3", "ArticleIdList": ["10.1007/s10719-016-9665-3", "27194526"]}, {"Citation": "Bjarnason I. (2013). Gastrointestinal safety of NSAIDs and over-the-counter analgesics. Int. J. Clin. Pract. 67, 37\u201342. 10.1111/ijcp.12048", "ArticleIdList": ["10.1111/ijcp.12048", "23163547"]}, {"Citation": "Brenn D., Richter F., Schaible H. G. (2007). Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: An inflammatory mechanism of joint pain. Arthritis Rheum. 56, 351\u2013359. 10.1002/art.22282", "ArticleIdList": ["10.1002/art.22282", "17195239"]}, {"Citation": "Brown M. B., Williams A. C. (2019). The art and science of dermal formulation development. London, NY: The Art and Science of Dermal Formulation Development."}, {"Citation": "Brun P., Zavan B., Vindigni V., Schiavinato A., Pozzuoli A., Iacobellis C., et al. (2012). In vitro response of osteoarthritic chondrocytes and fibroblast-like synoviocytes to a 500-730 kDa hyaluronan amide derivative. J. Biomed. Mat. Res. B Appl. Biomater. 100, 2073\u20132081. 10.1002/jbm.b.32771", "ArticleIdList": ["10.1002/jbm.b.32771", "22865740"]}, {"Citation": "Bruy\u00e8re O., Altman R. D., Reginster J. Y. (2016). Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin. Arthritis Rheum. 45, S12\u2013S17. 10.1016/j.semarthrit.2015.11.011", "ArticleIdList": ["10.1016/j.semarthrit.2015.11.011", "26806187"]}, {"Citation": "Burt H. M., Tsallas A., Gilchrist S., Liang L. S. (2009). Intra-articular drug delivery systems: Overcoming the shortcomings of joint disease therapy. Expert Opin. Drug Deliv. 6, 17\u201326. 10.1517/17425240802647259", "ArticleIdList": ["10.1517/17425240802647259", "19236205"]}, {"Citation": "Canavese G., Ancona A., Racca L., Canta M., Dumontel B., Barbaresco F., (2018). Nanoparticle-assisted ultrasound: A special focus on sonodynamic therapy against cancer. Chem. Eng. J. 340, 155\u2013172. 10.1016/j.cej.2018.01.060", "ArticleIdList": ["10.1016/j.cej.2018.01.060", "PMC6420022", "30881202"]}, {"Citation": "Chang C. C., Hsieh M. S., Liao S. T., Chen Y. H., Cheng C. W., Huang P. T., (2012). Hyaluronan regulates PPAR\u03b3 and inflammatory responses in IL-1\u03b2-stimulated human chondrosarcoma cells, a model for osteoarthritis. Carbohydr. Polym. 90, 1168\u20131175. 10.1016/j.carbpol.2012.06.071", "ArticleIdList": ["10.1016/j.carbpol.2012.06.071", "22840054"]}, {"Citation": "Chang M. C., Chiang P. F., Kuo Y. J., Peng C. L., Chen K. Y., Chiang Y. C. (2021). Hyaluronan-loaded liposomal dexamethasone-diclofenac nanoparticles for local osteoarthritis treatment. Int. J. Mol. Sci. 22, E665. 10.3390/ijms22020665", "ArticleIdList": ["10.3390/ijms22020665", "PMC7826786", "33440880"]}, {"Citation": "Chen C. G., Thuillier D., Chin E. N., Alliston T. (2012). Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis. Arthritis Rheum. 64, 3278\u20133289. 10.1002/art.34566", "ArticleIdList": ["10.1002/art.34566", "PMC3544176", "22674505"]}, {"Citation": "Chen D., Su X., Wang N., Li Y., Yin H., Li L., (2017). Chemical isotope labeling LC-MS for monitoring disease progression and treatment in animal models: Plasma metabolomics study of osteoarthritis rat model. Sci. Rep. 7, 40543. 10.1038/srep40543", "ArticleIdList": ["10.1038/srep40543", "PMC5238386", "28091618"]}, {"Citation": "Chen W. P., Xiong Y., Hu P. F., Bao J. P., Wu L. D. (2015). Baicalein inhibits MMPs expression via a MAPK-dependent mechanism in chondrocytes. Cell. Physiol. biochem. 36, 325\u2013333. 10.1159/000374075", "ArticleIdList": ["10.1159/000374075", "25967971"]}, {"Citation": "Chenoufi H. L., Diamant M., Rieneck K., Lund B., Stein G. S., Lian J. B. (2001). Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone. J. Cell. Biochem. 81, 666\u2013678. 10.1002/jcb.1104", "ArticleIdList": ["10.1002/jcb.1104", "11329621"]}, {"Citation": "Choi S., Park J., Hyun W., Kim J., Kim J., Lee Y. B., (2015). Stretchable heater using ligand-exchanged silver nanowire nanocomposite for wearable articular thermotherapy. ACS Nano 9, 6626\u20136633. 10.1021/acsnano.5b02790", "ArticleIdList": ["10.1021/acsnano.5b02790", "26027637"]}, {"Citation": "Conaghan P. G., Bowes M. A., Kingsbury S. R., Brett A., Guillard G., Rizoska B., (2020). Disease-modifying effects of a novel cathepsin K inhibitor in osteoarthritis: A randomized controlled trial. Ann. Intern. Med. 172, 86\u201395. 10.7326/m19-0675", "ArticleIdList": ["10.7326/m19-0675", "31887743"]}, {"Citation": "Console L., Scalise M., Indiveri C. (2019). Exosomes in inflammation and role as biomarkers. Clin. Chim. Acta. 488, 165\u2013171. 10.1016/j.cca.2018.11.009", "ArticleIdList": ["10.1016/j.cca.2018.11.009", "30419221"]}, {"Citation": "Dakin P., DiMartino S. J., Gao H., Maloney J., Kivitz A. J., Schnitzer T. J., (2019). The efficacy, tolerability, and joint safety of fasinumab in osteoarthritis pain: A phase IIb/III double-blind, placebo-controlled, randomized clinical trial, 71. Hoboken NJ): Arthritis & rheumatology, 1824\u20131834. 10.1002/art.41012", "ArticleIdList": ["10.1002/art.41012", "PMC6900077", "31207169"]}, {"Citation": "Eckstein F., Kraines J. L., Aydemir A., Wirth W., Maschek S., Hochberg M. C. (2020). Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: Post-hoc analysis of a randomised, placebo-controlled phase II clinical trial. Ann. Rheum. Dis. 79, 525\u2013528. 10.1136/annrheumdis-2019-216453", "ArticleIdList": ["10.1136/annrheumdis-2019-216453", "PMC7147175", "32098758"]}, {"Citation": "El Mansouri F. E., Chabane N., Zayed N., Kapoor M., Benderdour M., Martel-Pelletier J., (2011). Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes. Arthritis Rheum. 63, 168\u2013179. 10.1002/art.27762", "ArticleIdList": ["10.1002/art.27762", "20862685"]}, {"Citation": "Emami A., Tepper J., Short B., Yaksh T. L., Bendele A. M., Ramani T., (2018). Toxicology evaluation of drugs administered via uncommon routes: Intranasal, intraocular, intrathecal/intraspinal, and intra-articular. Int. J. Toxicol. 37, 4\u201327. 10.1177/1091581817741840", "ArticleIdList": ["10.1177/1091581817741840", "PMC5874330", "29264927"]}, {"Citation": "Evans C. H., Kraus V. B., Setton L. A. (2014). Progress in intra-articular therapy. Nat. Rev. Rheumatol. 10, 11\u201322. 10.1038/nrrheum.2013.159", "ArticleIdList": ["10.1038/nrrheum.2013.159", "PMC4402210", "24189839"]}, {"Citation": "Felson D. T. (2006). Clinical practice. Osteoarthritis of the knee. N. Engl. J. Med. 354, 841\u2013848. 10.1056/NEJMcp051726", "ArticleIdList": ["10.1056/NEJMcp051726", "16495396"]}, {"Citation": "Ferguson R. J., Palmer A. J., Taylor A., Porter M. L., Malchau H., Glyn-Jones S. (2018). Hip replacement. Lancet (London, Engl. 392, 1662\u20131671. 10.1016/s0140-6736(18)31777-x", "ArticleIdList": ["10.1016/s0140-6736(18)31777-x", "30496081"]}, {"Citation": "Ferreira R. M., Torres R. T., Duarte J. A., Gon\u00e7alves R. S. (2019). Non-pharmacological and non-surgical interventions for knee osteoarthritis: A systematic review and meta-analysis. Acta Reumatol. Port. 44, 173\u2013217.", "ArticleIdList": ["31356585"]}, {"Citation": "Fu L., Patel M. S., Bradley A., Wagner E. F., Karsenty G. (2005). The molecular clock mediates leptin-regulated bone formation. Cell 122, 803\u2013815. 10.1016/j.cell.2005.06.028", "ArticleIdList": ["10.1016/j.cell.2005.06.028", "16143109"]}, {"Citation": "Gao L. N., Zhong B., Wang Y. (2019). Mechanism underlying antitumor effects of sinomenine. Chin. J. Integr. Med. 25, 873\u2013878. 10.1007/s11655-019-3151-2", "ArticleIdList": ["10.1007/s11655-019-3151-2", "30826933"]}, {"Citation": "Garc\u00eda-Rayado G., Navarro M., Lanas A. (2018). NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs. Expert Rev. Clin. Pharmacol. 11, 1031\u20131043. 10.1080/17512433.2018.1516143", "ArticleIdList": ["10.1080/17512433.2018.1516143", "30139288"]}, {"Citation": "Gerwin N., Hops C., Lucke A. (2006). Intraarticular drug delivery in osteoarthritis. Adv. Drug Deliv. Rev. 58, 226\u2013242. 10.1016/j.addr.2006.01.018", "ArticleIdList": ["10.1016/j.addr.2006.01.018", "16574267"]}, {"Citation": "Ghosh R., Alajbegovic A., Gomes A. V. (2015). NSAIDs and cardiovascular diseases: Role of reactive oxygen species Oxid Med Cell Longev. 536962. 10.1155/2015/536962", "ArticleIdList": ["10.1155/2015/536962", "PMC4592725", "26457127"]}, {"Citation": "Guerne P. A., Carson D. A., Lotz M. (1990)., 144. Baltimore, Md, 499\u2013505.IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro J. Immunol.", "ArticleIdList": ["2104896"]}, {"Citation": "Gunson M. J., Arnett G. W., Milam S. B. (2012). Pathophysiology and pharmacologic control of osseous mandibular condylar resorption. J. Oral Maxillofac. Surg. 70, 1918\u20131934. 10.1016/j.joms.2011.07.018", "ArticleIdList": ["10.1016/j.joms.2011.07.018", "22014941"]}, {"Citation": "Guo H., Yin W., Zou Z., Zhang C., Sun M., Min L., (2021). Quercitrin alleviates cartilage extracellular matrix degradation and delays ACLT rat osteoarthritis development: An in vivo and in vitro study. J. Adv. Res. 28, 255\u2013267. 10.1016/j.jare.2020.06.020", "ArticleIdList": ["10.1016/j.jare.2020.06.020", "PMC7753236", "33364061"]}, {"Citation": "Gupta R. C., Lall R., Srivastava A., Sinha A. (2019). Hyaluronic acid: Molecular mechanisms and therapeutic trajectory. Front. Vet. Sci. 6, 192. 10.3389/fvets.2019.00192", "ArticleIdList": ["10.3389/fvets.2019.00192", "PMC6603175", "31294035"]}, {"Citation": "Hadgraft J., Lane M. E. (2005). Skin permeation: The years of enlightenment. Int. J. Pharm. 305, 2\u201312. 10.1016/j.ijpharm.2005.07.014", "ArticleIdList": ["10.1016/j.ijpharm.2005.07.014", "16246513"]}, {"Citation": "Harradine K. A., Akhurst R. J. (2006). Mutations of TGFbeta signaling molecules in human disease. Ann. Med. 38, 403\u2013414. 10.1080/07853890600919911", "ArticleIdList": ["10.1080/07853890600919911", "17008304"]}, {"Citation": "Hartmann K., Koenen M., Schauer S., Wittig-Blaich S., Ahmad M., Baschant U., (2016). Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol. Rev. 96, 409\u2013447. 10.1152/physrev.00011.2015", "ArticleIdList": ["10.1152/physrev.00011.2015", "26842265"]}, {"Citation": "Hellio le Graverand M. P., Clemmer R. S., Redifer P., Brunell R. M., Hayes C. W., Brandt K. D., (2013). A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann. Rheum. Dis. 72, 187\u2013195. 10.1136/annrheumdis-2012-202239", "ArticleIdList": ["10.1136/annrheumdis-2012-202239", "23144445"]}, {"Citation": "Henrotin Y., Marty M., Mobasheri A. (2014). What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas 78, 184\u2013187. 10.1016/j.maturitas.2014.04.015", "ArticleIdList": ["10.1016/j.maturitas.2014.04.015", "24861964"]}, {"Citation": "Henrotin Y., Mobasheri A., Marty M. (2012). Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? Arthritis Res. Ther. 14, 201. 10.1186/ar3657", "ArticleIdList": ["10.1186/ar3657", "PMC3392795", "22293240"]}, {"Citation": "Hiligsmann M., Cooper C., Arden N., Boers M., Branco J. C., Luisa Brandi M., (2013). Health economics in the field of osteoarthritis: An expert's consensus paper from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Semin. Arthritis Rheum. 43, 303\u2013313. 10.1016/j.semarthrit.2013.07.003", "ArticleIdList": ["10.1016/j.semarthrit.2013.07.003", "23992801"]}, {"Citation": "Homayun B., Lin X., Choi H. J. (2019). Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics 11, E129. 10.3390/pharmaceutics11030129", "ArticleIdList": ["10.3390/pharmaceutics11030129", "PMC6471246", "30893852"]}, {"Citation": "How K. N., Yap W. H., Lim C. L. H., Goh B. H., Lai Z. W. (2020). Hyaluronic acid-mediated drug delivery system targeting for inflammatory skin diseases: A mini review. Front. Pharmacol. 11, 1105. 10.3389/fphar.2020.01105", "ArticleIdList": ["10.3389/fphar.2020.01105", "PMC7397973", "32848737"]}, {"Citation": "Hs D. J., Kong W. H., Sung D. K., Lee M. Y., Beack S. E., Keum D. H., (2014). Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer. ACS Nano 8, 260\u2013268. 10.1021/nn405383a", "ArticleIdList": ["10.1021/nn405383a", "24383990"]}, {"Citation": "Hu J., Zhou J., Wu J., Chen Q., Du W., Fu F., (2020). Loganin ameliorates cartilage degeneration and osteoarthritis development in an osteoarthritis mouse model through inhibition of NF-\u03baB activity and pyroptosis in chondrocytes. J. Ethnopharmacol. 247, 112261. 10.1016/j.jep.2019.112261", "ArticleIdList": ["10.1016/j.jep.2019.112261", "31577939"]}, {"Citation": "Hunter D. J., Bierma-Zeinstra S. (2019). Osteoarthritis. Lancet (London, Engl. 393, 1745\u20131759. 10.1016/s0140-6736(19)30417-9", "ArticleIdList": ["10.1016/s0140-6736(19)30417-9", "31034380"]}, {"Citation": "Hunter D. J. (2011). Pharmacologic therapy for osteoarthritis--the era of disease modification. Nat. Rev. Rheumatol. 7, 13\u201322. 10.1038/nrrheum.2010.178", "ArticleIdList": ["10.1038/nrrheum.2010.178", "21079644"]}, {"Citation": "Hussain S. M., Neilly D. W., Baliga S., Patil S., Meek R. (2016). Knee osteoarthritis: A review of management options. Scott. Med. J. 61, 7\u201316. 10.1177/0036933015619588", "ArticleIdList": ["10.1177/0036933015619588", "27330013"]}, {"Citation": "Ivanovska N., Dimitrova P. (2011). Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine. Arthritis Res. Ther. 13, R44. 10.1186/ar3283", "ArticleIdList": ["10.1186/ar3283", "PMC3132029", "21410959"]}, {"Citation": "Kalia Y. N., Naik A., Garrison J., Guy R. H. (2004). Iontophoretic drug delivery. Adv. Drug Deliv. Rev. 56, 619\u2013658. 10.1016/j.addr.2003.10.026", "ArticleIdList": ["10.1016/j.addr.2003.10.026", "15019750"]}, {"Citation": "Kaneshiro T., Morioka T., Inamine M., Kinjo T., Arakaki J., Chiba I., (2006). Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. Eur. J. Pharmacol. 553, 46\u201353. 10.1016/j.ejphar.2006.09.026", "ArticleIdList": ["10.1016/j.ejphar.2006.09.026", "17056031"]}, {"Citation": "Karsdal M. A., Michaelis M., Ladel C., Siebuhr A. S., Bihlet A. R., Andersen J. R., (2016). Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: Lessons learned from failures and opportunities for the future. Osteoarthr. Cartil. 24, 2013\u20132021. 10.1016/j.joca.2016.07.017", "ArticleIdList": ["10.1016/j.joca.2016.07.017", "27492463"]}, {"Citation": "Katsara O., Attur M., Ruoff R., Abramson S. B., Kolupaeva V. (2017). Increased activity of the chondrocyte translational apparatus accompanies osteoarthritic changes in human and rodent knee cartilage, 69. Hoboken, NJ): Arthritis & rheumatology, 586\u2013597. 10.1002/art.39947", "ArticleIdList": ["10.1002/art.39947", "PMC5329137", "27696794"]}, {"Citation": "Kennedy J., Larra\u00f1eta E., McCrudden M. T. C., McCrudden C. M., Brady A. J., Fallows S. J., (2017). In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles. J. Control. Release 265, 57\u201365. 10.1016/j.jconrel.2017.04.022", "ArticleIdList": ["10.1016/j.jconrel.2017.04.022", "PMC5736098", "28428065"]}, {"Citation": "Kim Y. S., Hwang C. S., Shin D. H. (2005). Volatile constituents from the leaves of Polygonum cuspidatum S. et Z. and their anti-bacterial activities. Food Microbiol. 22, 139\u2013144. 10.1016/j.fm.2004.01.016", "ArticleIdList": ["10.1016/j.fm.2004.01.016"]}, {"Citation": "Kishida Y., Hirao M., Tamai N., Nampei A., Fujimoto T., Nakase T., (2005). Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification. Bone 37, 607\u2013621. 10.1016/j.bone.2005.05.009", "ArticleIdList": ["10.1016/j.bone.2005.05.009", "16039170"]}, {"Citation": "Kloppenburg M., Peterfy C., Haugen I. K., Kroon F., Chen S., Wang L., (2019). Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1\u03b1 and anti-interleukin-1\u03b2 dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Ann. Rheum. Dis. 78, 413\u2013420. 10.1136/annrheumdis-2018-213336", "ArticleIdList": ["10.1136/annrheumdis-2018-213336", "PMC6390132", "30552176"]}, {"Citation": "Kolhe R., Hunter M., Liu S., Jadeja R. N., Pundkar C., Mondal A. K., (2017). Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis. Sci. Rep. 7, 2029. 10.1038/s41598-017-01905-y", "ArticleIdList": ["10.1038/s41598-017-01905-y", "PMC5435729", "28515465"]}, {"Citation": "Koskinen A., Vuolteenaho K., Nieminen R., Moilanen T., Moilanen E. (2011). Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients. Clin. Exp. Rheumatol. 29, 57\u201364.", "ArticleIdList": ["21345293"]}, {"Citation": "Kwan Tat S., Padrines M., Th\u00e9oleyre S., Heymann D., Fortun Y. (2004). IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15, 49\u201360. 10.1016/j.cytogfr.2003.10.005", "ArticleIdList": ["10.1016/j.cytogfr.2003.10.005", "14746813"]}, {"Citation": "Lee H., Song C., Baik S., Kim D., Hyeon T., Kim D. H. (2018). Device-assisted transdermal drug delivery. Adv. Drug Deliv. Rev. 127, 35\u201345. 10.1016/j.addr.2017.08.009", "ArticleIdList": ["10.1016/j.addr.2017.08.009", "28867296"]}, {"Citation": "Li B., Chen K., Qian N., Huang P., Hu F., Ding T., (2021). Baicalein alleviates osteoarthritis by protecting subchondral bone, inhibiting angiogenesis and synovial proliferation. J. Cell. Mol. Med. 25, 5283\u20135294. 10.1111/jcmm.16538", "ArticleIdList": ["10.1111/jcmm.16538", "PMC8178278", "33939310"]}, {"Citation": "Li X., Wu D., Hu Z., Xuan J., Ding X., Zheng G., (2018). The protective effect of Ligustilide in osteoarthritis: An in vitro and in vivo study. Cell. Physiol. biochem. 48, 2583\u20132595. 10.1159/000492701", "ArticleIdList": ["10.1159/000492701", "30121673"]}, {"Citation": "Li Y., Wang Y., Chubinskaya S., Schoeberl B., Florine E., Kopesky P., (2015). Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: Relevance to post-traumatic osteoarthritis. Osteoarthr. Cartil. 23, 266\u2013274. 10.1016/j.joca.2014.11.006", "ArticleIdList": ["10.1016/j.joca.2014.11.006", "PMC4304966", "25450855"]}, {"Citation": "Lin M. L., Lu Y. C., Chung J. G., Wang S. G., Lin H. T., Kang S. E., (2010). Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion. Mol. Carcinog. 49, 783\u2013797. 10.1002/mc.20652", "ArticleIdList": ["10.1002/mc.20652", "20607722"]}, {"Citation": "Litwiniuk M., Krejner A., Speyrer M. S., Gauto A. R., Grzela T. (2016). Hyaluronic acid in inflammation and tissue regeneration. Wounds. 28, 78\u201388.", "ArticleIdList": ["26978861"]}, {"Citation": "Liu J., Pan J., Wang Y., Lin D., Shen D., Yang H., (2013). Component analysis of Chinese medicine and advances in fuming-washing therapy for knee osteoarthritis via unsupervised data mining methods. J. traditional Chin. Med. = Chung i tsa chih ying wen pan 33, 686\u2013691. 10.1016/s0254-6272(14)60043-1", "ArticleIdList": ["10.1016/s0254-6272(14)60043-1", "24660597"]}, {"Citation": "Liu W., Zhang Y., Zhu W., Ma C., Ruan J., Long H., (2018). Sinomenine inhibits the progression of rheumatoid arthritis by regulating the secretion of inflammatory cytokines and monocyte/macrophage subsets. Front. Immunol. 9, 2228. 10.3389/fimmu.2018.02228", "ArticleIdList": ["10.3389/fimmu.2018.02228", "PMC6168735", "30319663"]}, {"Citation": "Loeser R. F., Collins J. A., Diekman B. O. (2016). Ageing and the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12, 412\u2013420. 10.1038/nrrheum.2016.65", "ArticleIdList": ["10.1038/nrrheum.2016.65", "PMC4938009", "27192932"]}, {"Citation": "Lotz M. K., Caram\u00e9s B. (2011). Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA. Nat. Rev. Rheumatol. 7, 579\u2013587. 10.1038/nrrheum.2011.109", "ArticleIdList": ["10.1038/nrrheum.2011.109", "PMC3192496", "21808292"]}, {"Citation": "Lu S., Xiao X., Cheng M. (2015). Matrine inhibits IL-1\u03b2-induced expression of matrix metalloproteinases by suppressing the activation of MAPK and NF-\u03baB in human chondrocytes in vitro . Int. J. Clin. Exp. Pathol. 8, 4764\u20134772.", "ArticleIdList": ["PMC4503038", "26191166"]}, {"Citation": "Lu Y. C., Evans C. H., Grodzinsky A. J. (2011). Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines. Arthritis Res. Ther. 13, R142. 10.1186/ar3456", "ArticleIdList": ["10.1186/ar3456", "PMC3308070", "21888631"]}, {"Citation": "Martel-Pelletier J., Barr A. J., Cicuttini F. M., Conaghan P. G., Cooper C., Goldring M. B., et al. (2016). Nat. Rev. Dis. Prim. 2, 16072. 10.1038/nrdp.2016.72", "ArticleIdList": ["10.1038/nrdp.2016.72", "27734845"]}, {"Citation": "Maudens P., Jordan O., All\u00e9mann E. (2018). Recent advances in intra-articular drug delivery systems for osteoarthritis therapy. Drug Discov. Today 23, 1761\u20131775. 10.1016/j.drudis.2018.05.023", "ArticleIdList": ["10.1016/j.drudis.2018.05.023", "29792929"]}, {"Citation": "McDonough A. K., Curtis J. R., Saag K. G. (2008). The epidemiology of glucocorticoid-associated adverse events. Curr. Opin. Rheumatol. 20, 131\u2013137. 10.1097/BOR.0b013e3282f51031", "ArticleIdList": ["10.1097/BOR.0b013e3282f51031", "18349741"]}, {"Citation": "Meng J., Li L. (2017). The efficiency and safety of dexamethasone for pain control in total joint arthroplasty: A meta-analysis of randomized controlled trials. Medicine 96, e7126. 10.1097/md.0000000000007126", "ArticleIdList": ["10.1097/md.0000000000007126", "PMC5478317", "28614232"]}, {"Citation": "Mengshol J. A., Vincenti M. P., Coon C. I., Barchowsky A., Brinckerhoff C. E. (2000). Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-jun N-terminal kinase, and nuclear factor kappaB: Differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43, 801\u2013811. 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4 ;2-4", "ArticleIdList": ["10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4", "10765924"]}, {"Citation": "Mihailidou C., Panagiotou C., Kiaris H., Kassi E., Moutsatsou P. (2016). Crosstalk between C/EBP homologous protein (CHOP) and glucocorticoid receptor in lung cancer. Mol. Cell. Endocrinol. 436, 211\u2013223. 10.1016/j.mce.2016.08.001", "ArticleIdList": ["10.1016/j.mce.2016.08.001", "27496643"]}, {"Citation": "Moqbel S. A. A., He Y., Xu L., Ma C., Ran J., Xu K., et al. (2020). Rat chondrocyte inflammation and osteoarthritis are ameliorated by madecassoside. Oxidative medicine and cellular longevity, 2020. 10.1155/2020/7540197 7540197", "ArticleIdList": ["10.1155/2020/7540197", "PMC7023724", "32089778"]}, {"Citation": "Ogata T., Ideno Y., Akai M., Seichi A., Hagino H., Iwaya T., (2018). Effects of glucosamine in patients with osteoarthritis of the knee: A systematic review and meta-analysis. Clin. Rheumatol. 37, 2479\u20132487. 10.1007/s10067-018-4106-2", "ArticleIdList": ["10.1007/s10067-018-4106-2", "PMC6097075", "29713967"]}, {"Citation": "Park D., Song G., Jo Y., Won J., Son T., Cha O., (2016). Sonophoresis using ultrasound contrast agents: Dependence on concentration. PloS one 11, e0157707. 10.1371/journal.pone.0157707", "ArticleIdList": ["10.1371/journal.pone.0157707", "PMC4913954", "27322539"]}, {"Citation": "Park E., Lee C. G., Han S. J., Yun S. H., Hwang S., Jeon H., (2021). Antiosteoarthritic effect of morroniside in chondrocyte inflammation and destabilization of medial meniscus-induced mouse model. Int. J. Mol. Sci. 22, 2987. 10.3390/ijms22062987", "ArticleIdList": ["10.3390/ijms22062987", "PMC7999654", "33804203"]}, {"Citation": "Pelletier J. P., Roubille C., Raynauld J. P., Abram F., Dorais M., Delorme P., (2015). Disease-modifying effect of strontium ranelate in a subset of patients from the phase III knee osteoarthritis study SEKOIA using quantitative MRI: Reduction in bone marrow lesions protects against cartilage loss. Ann. Rheum. Dis. 74, 422\u2013429. 10.1136/annrheumdis-2013-203989", "ArticleIdList": ["10.1136/annrheumdis-2013-203989", "24297379"]}, {"Citation": "Pohlig F., Guell F., Lenze U., Lenze F. W., M\u00fchlhofer H. M., Schauwecker J., et al. (2016). Hyaluronic acid suppresses the expression of metalloproteinases in osteoarthritic cartilage stimulated simultaneously by interleukin 1\u03b2 and mechanical load. PloS one 11, e0150020. 10.1371/journal.pone.0150020", "ArticleIdList": ["10.1371/journal.pone.0150020", "PMC4774918", "26934732"]}, {"Citation": "Polderman J. A. W., Farhang-Razi V., van Dieren S., Kranke P., DeVries J. H., Hollmann M. W., (2019). Adverse side-effects of dexamethasone in surgical patients - an abridged Cochrane systematic review. Anaesthesia 74, 929\u2013939. 10.1111/anae.14610", "ArticleIdList": ["10.1111/anae.14610", "30821852"]}, {"Citation": "Pontes-Quero G. M., Garc\u00eda-Fern\u00e1ndez L., Aguilar M. R., San Rom\u00e1n J., P\u00e9rez Cano J., V\u00e1zquez-Lasa B. (2019). Active viscosupplements for osteoarthritis treatment. Semin. Arthritis Rheum. 49, 171\u2013183. 10.1016/j.semarthrit.2019.02.008", "ArticleIdList": ["10.1016/j.semarthrit.2019.02.008", "30878154"]}, {"Citation": "Por\u00e9e B., Kypriotou M., Chadjichristos C., Beauchef G., Renard E., Legendre F., (2008). Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J. Biol. Chem. 283, 4850\u20134865. 10.1074/jbc.M706387200", "ArticleIdList": ["10.1074/jbc.M706387200", "18065760"]}, {"Citation": "Pozgan U., Caglic D., Rozman B., Nagase H., Turk V., Turk B. (2010). Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Biol. Chem. 391, 571\u2013579. 10.1515/bc.2010.035", "ArticleIdList": ["10.1515/bc.2010.035", "20180636"]}, {"Citation": "Prausnitz M. R., Langer R. (2008). Transdermal drug delivery. Nat. Biotechnol. 26, 1261\u20131268. 10.1038/nbt.1504", "ArticleIdList": ["10.1038/nbt.1504", "PMC2700785", "18997767"]}, {"Citation": "Rahmati M., Nalesso G., Mobasheri A., Mozafari M. (2017). Aging and osteoarthritis: Central role of the extracellular matrix. Ageing Res. Rev. 40, 20\u201330. 10.1016/j.arr.2017.07.004", "ArticleIdList": ["10.1016/j.arr.2017.07.004", "28774716"]}, {"Citation": "Robinson P. D., McEwan J., Adukia V., Prabhakar M. (2018). Osteoarthritis and arthroplasty of the hip and knee, 79. London England UK: British journal of hospital medicine, C54\u2013c9. 10.12968/hmed.2018.79.4.C54", "ArticleIdList": ["10.12968/hmed.2018.79.4.C54", "29620976"]}, {"Citation": "Roman-Blas J. A., Casta\u00f1eda S., S\u00e1nchez-Pernaute O., Largo R., Herrero-Beaumont G. (2017). Combined treatment with chondroitin sulfate and glucosamine sulfate shows No superiority over placebo for reduction of joint pain and functional impairment in patients with knee osteoarthritis: A six-month multicenter, randomized, double-blind, placebo-controlled clinical trial, 69. Hoboken NJ: ): Arthritis & rheumatology, 77\u201385. 10.1002/art.39819", "ArticleIdList": ["10.1002/art.39819", "27477804"]}, {"Citation": "Rowan A. D., Koshy P. J., Shingleton W. D., Degnan B. A., Heath J. K., Vernallis A. B., (2001). Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum. 44, 1620\u20131632. 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B", "ArticleIdList": ["10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B", "11465713"]}, {"Citation": "Runhaar J., Rozendaal R. M., van Middelkoop M., Bijlsma H. J. W., Doherty M., Dziedzic K. S., (2017). Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: A systematic review and individual patient data meta-analysis from the OA trial bank. Ann. Rheum. Dis. 76, 1862\u20131869. 10.1136/annrheumdis-2017-211149", "ArticleIdList": ["10.1136/annrheumdis-2017-211149", "28754801"]}, {"Citation": "Sakao K., Takahashi K. A., Arai Y., Saito M., Honjo K., Hiraoka N., (2009). Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis. J. Bone Min. Metab. 27, 412\u2013423. 10.1007/s00774-009-0058-6", "ArticleIdList": ["10.1007/s00774-009-0058-6", "19333684"]}, {"Citation": "Salvi V., Gianello V., Busatto S., Bergese P., Andreoli L., D'Oro U., (2018). Exosome-delivered microRNAs promote IFN-\u03b1 secretion by human plasmacytoid DCs via TLR7. JCI insight 3, 98204. 10.1172/jci.insight.98204", "ArticleIdList": ["10.1172/jci.insight.98204", "PMC6012509", "29769437"]}, {"Citation": "Sant S., Tao S. L., Fisher O. Z., Xu Q., Peppas N. A., Khademhosseini A. (2012). Microfabrication technologies for oral drug delivery. Adv. Drug Deliv. Rev. 64, 496\u2013507. 10.1016/j.addr.2011.11.013", "ArticleIdList": ["10.1016/j.addr.2011.11.013", "PMC3534972", "22166590"]}, {"Citation": "Sastry S. V., Nyshadham J. R., Fix J. A. (2000). Recent technological advances in oral drug delivery - a review. Pharm. Sci. Technol. Today 3, 138\u2013145. 10.1016/s1461-5347(00)00247-9", "ArticleIdList": ["10.1016/s1461-5347(00)00247-9", "10754543"]}, {"Citation": "S\u00e9guin C. A., Bernier S. M. (2003). TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways. J. Cell. Physiol. 197, 356\u2013369. 10.1002/jcp.10371", "ArticleIdList": ["10.1002/jcp.10371", "14566965"]}, {"Citation": "Shen J., Li J., Wang B., Jin H., Wang M., Zhang Y., (2013). Deletion of the transforming growth factor \u03b2 receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice. Arthritis Rheum. 65, 3107\u20133119. 10.1002/art.38122", "ArticleIdList": ["10.1002/art.38122", "PMC3928444", "23982761"]}, {"Citation": "Simental-Mend\u00eda M., S\u00e1nchez-Garc\u00eda A., Vilchez-Cavazos F., Acosta-Olivo C. A., Pe\u00f1a-Mart\u00ednez V. M., Simental-Mend\u00eda L. E. (2018). Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: A systematic review and meta-analysis of randomized placebo-controlled trials. Rheumatol. Int. 38, 1413\u20131428. 10.1007/s00296-018-4077-2", "ArticleIdList": ["10.1007/s00296-018-4077-2", "29947998"]}, {"Citation": "Simopoulou T., Malizos K. N., Iliopoulos D., Stefanou N., Papatheodorou L., Ioannou M., (2007). Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthr. Cartil. 15, 872\u2013883. 10.1016/j.joca.2007.01.018", "ArticleIdList": ["10.1016/j.joca.2007.01.018", "17350295"]}, {"Citation": "Singh J. A., Noorbaloochi S., MacDonald R., Maxwell L. J. (2015). Chondroitin for osteoarthritis. Cochrane Database Syst. Rev. 1, Cd005614. 10.1002/14651858.CD005614.pub2", "ArticleIdList": ["10.1002/14651858.CD005614.pub2", "PMC4881293", "25629804"]}, {"Citation": "Song W., Ni S., Fu Y., Wang Y. (2018). Uncovering the mechanism of maxing ganshi decoction on asthma from a systematic perspective: A network pharmacology study. Sci. Rep. 8, 17362. 10.1038/s41598-018-35791-9", "ArticleIdList": ["10.1038/s41598-018-35791-9", "PMC6255815", "30478434"]}, {"Citation": "Stannus O., Jones G., Cicuttini F., Parameswaran V., Quinn S., Burgess J., (2010). Circulating levels of IL-6 and TNF-\u03b1 are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthr. Cartil. 18, 1441\u20131447. 10.1016/j.joca.2010.08.016", "ArticleIdList": ["10.1016/j.joca.2010.08.016", "20816981"]}, {"Citation": "Stevens R. M., Ervin J., Nezzer J., Nieves Y., Guedes K., Burges R., (2019)., 71. Hoboken, NJ: ): Arthritis & rheumatology, 1524\u20131533. 10.1002/art.40894 Randomized, double-blindPlacebo-Controlled Trial Intraarticular Trans-Capsaicin Pain Assoc. Osteoarthr. Knee", "ArticleIdList": ["10.1002/art.40894", "PMC6772016", "30888737"]}, {"Citation": "Tai F. W. D., McAlindon M. E. (2018). NSAIDs and the small bowel. Curr. Opin. Gastroenterol. 34, 175\u2013182. 10.1097/mog.0000000000000427", "ArticleIdList": ["10.1097/mog.0000000000000427", "29438118"]}, {"Citation": "Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K. L., et al. (2002). Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305\u2013317. 10.1016/s0092-8674(02)01049-8", "ArticleIdList": ["10.1016/s0092-8674(02)01049-8", "12419242"]}, {"Citation": "Toussirot E., Streit G., Wendling D. (2007). The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr. Med. Chem. 14, 1095\u20131100. 10.2174/092986707780362826", "ArticleIdList": ["10.2174/092986707780362826", "17456023"]}, {"Citation": "Towheed T. E., Maxwell L., Anastassiades T. P., Shea B., Houpt J., Robinson V., (2005). Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst. Rev. 2005, Cd002946. 10.1002/14651858.CD002946.pub2", "ArticleIdList": ["10.1002/14651858.CD002946.pub2", "PMC8459392", "15846645"]}, {"Citation": "Uebelhart D., Malaise M., Marcolongo R., de Vathaire F., Piperno M., Mailleux E., (2004). Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: A one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthr. Cartil. 12, 269\u2013276. 10.1016/j.joca.2004.01.004", "ArticleIdList": ["10.1016/j.joca.2004.01.004", "15023378"]}, {"Citation": "Uwe S. (2008). Anti-inflammatory interventions of NF-kappaB signaling: Potential applications and risks. Biochem. Pharmacol. 75, 1567\u20131579. 10.1016/j.bcp.2007.10.027", "ArticleIdList": ["10.1016/j.bcp.2007.10.027", "18070616"]}, {"Citation": "van de Graaf V. A., Noorduyn J. C. A., Willigenburg N. W., Butter I. K., de Gast A., Mol B. W., (2018). Effect of early surgery vs physical therapy on knee function among patients with nonobstructive meniscal tears: The ESCAPE randomized clinical trial. Jama 320, 1328\u20131337. 10.1001/jama.2018.13308", "ArticleIdList": ["10.1001/jama.2018.13308", "PMC6583004", "30285177"]}, {"Citation": "Vignon E., Valat J. P., Rossignol M., Avouac B., Rozenberg S., Thoumie P., et al. (2006). Osteoarthritis of the knee and hip and activity: A systematic international review and synthesis (OASIS). Jt. bone spine 73, 442\u2013455. 10.1016/j.jbspin.2006.03.001", "ArticleIdList": ["10.1016/j.jbspin.2006.03.001", "16777458"]}, {"Citation": "Vos T., Flaxman A. D., Naghavi M., Lozano R., Michaud C., Ezzati M., et al. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet (London, Engl. 380, 2163\u20132196. 10.1016/s0140-6736(12)61729-2", "ArticleIdList": ["10.1016/s0140-6736(12)61729-2", "PMC6350784", "23245607"]}, {"Citation": "Vuolteenaho K., Koskinen A., Kukkonen M., Nieminen R., P\u00e4iv\u00e4rinta U., Moilanen T., et al. (2009). Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage--mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediat. Inflamm. 2009, 345838. 10.1155/2009/345838", "ArticleIdList": ["10.1155/2009/345838", "PMC2726438", "19688109"]}, {"Citation": "Wang J., Ma J., Gu J. H., Wang F. Y., Shang X. S., Tao H. R., (2017). Regulation of type II collagen, matrix metalloproteinase-13 and cell proliferation by interleukin-1\u03b2 is mediated by curcumin via inhibition of NF-\u03baB signaling in rat chondrocytes. Mol. Med. Rep. 16, 1837\u20131845. 10.3892/mmr.2017.6771", "ArticleIdList": ["10.3892/mmr.2017.6771", "PMC5562050", "28627596"]}, {"Citation": "Wang L., Shao Y. Y., Ballock R. T. (2012). Leptin antagonizes peroxisome proliferator-activated receptor-\u03b3 signaling in growth plate chondrocytes. PPAR Res. 2012, 756198. 10.1155/2012/756198", "ArticleIdList": ["10.1155/2012/756198", "PMC3458404", "23028384"]}, {"Citation": "Wang Q., Zhuang D., Feng W., Ma B., Qin L., Jin L. (2020)., 28. the official publication of the Saudi Pharmaceutical Society, 1499\u20131506. 10.1016/j.jsps.2020.09.016 Fraxetin inhibits interleukin-1\u03b2-induced apoptosis, inflammation, and matrix degradation in chondrocytes and protects rat cartilage in vivo , Saudi Pharm. J. SPJ", "ArticleIdList": ["10.1016/j.jsps.2020.09.016", "PMC7783108", "33424243"]}, {"Citation": "Wang R., Kong J., Wang D., Lien L. L., Lien E. J. (2007). A survey of Chinese herbal ingredients with liver protection activities. Chin. Med. 2, 5. 10.1186/1749-8546-2-5", "ArticleIdList": ["10.1186/1749-8546-2-5", "PMC1876451", "17490493"]}, {"Citation": "Xu X., Liu X., Yang Y., He J., Gu H., Jiang M., (2019). Resveratrol inhibits the development of obesity-related osteoarthritis via the TLR4 and PI3K/Akt signaling pathways. Connect. Tissue Res. 60, 571\u2013582. 10.1080/03008207.2019.1601187", "ArticleIdList": ["10.1080/03008207.2019.1601187", "30922122"]}, {"Citation": "Xue J., Wang J., Liu Q., Luo A. (2013). Tumor necrosis factor-\u03b1 induces ADAMTS-4 expression in human osteoarthritis chondrocytes. Mol. Med. Rep. 8, 1755\u20131760. 10.3892/mmr.2013.1729", "ArticleIdList": ["10.3892/mmr.2013.1729", "24126638"]}, {"Citation": "Yan D., He B., Guo J., Li S., Wang J. (2019). Involvement of TLR4 in the protective effect of intra-articular administration of curcumin on rat experimental osteoarthritis. Acta Cir. Bras. 34, e201900604. 10.1590/s0102-865020190060000004", "ArticleIdList": ["10.1590/s0102-865020190060000004", "PMC6705335", "31432995"]}, {"Citation": "Yang X., Chen L., Xu X., Li C., Huang C., Deng C. X. (2001). TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol. 153, 35\u201346. 10.1083/jcb.153.1.35", "ArticleIdList": ["10.1083/jcb.153.1.35", "PMC2185521", "11285272"]}, {"Citation": "Yang Y., Gu Y., Zhao H., Zhang S. (2019). Loganin attenuates osteoarthritis in rats by inhibiting IL-1\u03b2-induced catabolism and apoptosis in chondrocytes via regulation of phosphatidylinositol 3-kinases (PI3K)/Akt. Med. Sci. Monit. 25, 4159\u20134168. 10.12659/msm.915064", "ArticleIdList": ["10.12659/msm.915064", "PMC6561138", "31162482"]}, {"Citation": "Yin K., Smith A. G. (2016). Nuclear receptor function in skin health and disease: Therapeutic opportunities in the orphan and adopted receptor classes. Cell. Mol. Life Sci. 73, 3789\u20133800. 10.1007/s00018-016-2329-4", "ArticleIdList": ["10.1007/s00018-016-2329-4", "27544210"]}, {"Citation": "You L., Feng S., An R., Wang X. (2009). Osthole: A promising lead compound for drug discovery from a traditional Chinese medicine (TCM). Nat. Prod. Commun. 4, 1934578X0900400\u2013302. 10.1177/1934578x0900400227", "ArticleIdList": ["10.1177/1934578x0900400227", "19370943"]}, {"Citation": "Yu H., Yao S., Zhou C., Fu F., Luo H., Du W., et al. (2021). Morroniside attenuates apoptosis and pyroptosis of chondrocytes and ameliorates osteoarthritic development by inhibiting NF-\u03baB signaling. J. Ethnopharmacol. 266, 113447. 10.1016/j.jep.2020.113447", "ArticleIdList": ["10.1016/j.jep.2020.113447", "33022338"]}, {"Citation": "Zhang G., Cao J., Yang E., Liang B., Ding J., Liang J., (2018). Curcumin improves age-related and surgically induced osteoarthritis by promoting autophagy in mice. Biosci. Rep. 38, BSR20171691. 10.1042/bsr20171691", "ArticleIdList": ["10.1042/bsr20171691", "PMC6028754", "29802156"]}, {"Citation": "Zhang H., Chen L., Sun X., Yang Q., Wan L., Matrine Guo C. (2020). Matrine: A promising natural product with various pharmacological activities. Front. Pharmacol. 11, 588. 10.3389/fphar.2020.00588", "ArticleIdList": ["10.3389/fphar.2020.00588", "PMC7232545", "32477114"]}, {"Citation": "Zhang X., Ziran N., Goater J. J., Schwarz E. M., Puzas J. E., Rosier R. N., (2004). Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 34, 809\u2013817. 10.1016/j.bone.2003.12.026", "ArticleIdList": ["10.1016/j.bone.2003.12.026", "15121012"]}, {"Citation": "Zhang Y., Chen X., Tong Y., Luo J., Bi Q. (2020). Development and prospect of intra-articular injection in the treatment of osteoarthritis: A review. J. Pain Res. 13, 1941\u20131955. 10.2147/jpr.S260878", "ArticleIdList": ["10.2147/jpr.S260878", "PMC7414982", "32801850"]}, {"Citation": "Zhang Z. R., Leung W. N., Cheung H. Y., Chan C. W. (2015). Osthole: A review on its bioactivities, pharmacological properties, and potential as alternative medicine. Evidence-Based complementary and alternative medicine : eCAM, 2015. 10.1155/2015/919616 919616", "ArticleIdList": ["10.1155/2015/919616", "PMC4515521", "26246843"]}, {"Citation": "Zhao B. (2017). TNF and bone remodeling. Curr. Osteoporos. Rep. 15, 126\u2013134. 10.1007/s11914-017-0358-z", "ArticleIdList": ["10.1007/s11914-017-0358-z", "PMC6408950", "28477234"]}, {"Citation": "Zimmermann G. R., Avery W., Finelli A. L., Farwell M., Fraser C. C., Borisy A. A. (2009). Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drug. Arthritis Res. Ther. 11, 11R12. 10.1186/ar2602", "ArticleIdList": ["10.1186/ar2602", "PMC2688244", "19171052"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "24"}, {"Year": "2022", "Month": "11", "Day": "3"}, {"Year": "2022", "Month": "12", "Day": "5", "Hour": "4", "Minute": "17"}, {"Year": "2022", "Month": "12", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "11", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["36467045", "PMC9712996", "10.3389/fphar.2022.945876", "945876"]}}], "PubmedBookArticle": []}